Drugs / HyperAcute-Lung Cancer Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00420732 | Jan 2007 → Nov 2012 | non-small cell lung carcinoma | NewLink Genetics Corporation | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HyperAcute-Lung Cancer Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00420732 ↗ |
| Modality | Vaccine | “anti-tumor vaccine” NCT00420732 ↗ |